Eisai, Nitto Denko to Co-develop Transdermal Formulation of Alzheimer's Disease Agent ARICEPT.
Under the agreement terms, the two companies will collaborate in developing a transdermal formulation (adhesive tape) of ARICEPT, an agent for treating Alzheimer's disease.
Nitto Denko, a Japanese leading liquid-crystal film manufacturer, has established various methods for drug formulation design. In particular, the company retains expertise in synthesizing adhesive materials suitable for controlled release.
Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
|Printer friendly Cite/link Email Feedback|
|Publication:||JCNN News Summaries|
|Date:||May 11, 2006|
|Previous Article:||Novartis Pharma, Chugai Pharmaceutical to Ship Agent for Postmenopausal Breast Cancer.|
|Next Article:||AnGes MG Announces Results of Phase I Clinical Trial of HGF Gene Medicine.|